Tilray Brands (TLRY) Payables (2017 - 2026)
Tilray Brands' (TLRY) quarterly Payables came in at $326.9 million in Q2 2026, up 34.79% YoY from $242.5 million in Q2 2025, and up 40.39% on a QoQ basis from $232.8 million in Q1 2026.
Tilray Brands (TLRY) Payables (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Payables data on file, last reported at $326.9 million in Q2 2026.
- Quarterly Payables rose 34.79% year-over-year to $326.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $326.9 million (up 34.79% YoY) and the FY2026 annual result came in at $326.9 million, up 34.79% from the prior year.
- Payables climbed to $326.9 million in Q2 2026, from $232.8 million in the prior quarter.
- In the past five years, Payables ranged from a high of $326.9 million in Q2 2026 to a low of $154.6 million in Q1 2022.
- A 5-year average of $224.3 million and a median of $233.9 million in 2025 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables declined 20.75% — and 2023, when it surged 46.1%.
- Tracing TLRY's Payables over 5 years: stood at $178.2 million in 2022, then surged by 33.04% to $237.1 million in 2023, then rose by 0.99% to $239.4 million in 2024, then slipped by 1.85% to $235.0 million in 2025, then surged by 39.1% to $326.9 million in 2026.
- The last three Payables figures came in at $326.9 million (Q2 2026), $232.8 million (Q1 2026), and $235.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 986.00 Mn |
| 10 | Tilray Brands | 512.61 Mn | 277.98 Mn | 90.52 Mn | 326.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 326.86 Mn |
| Feb 28, 2026 | 232.83 Mn |
| Nov 30, 2025 | 234.99 Mn |
| Aug 31, 2025 | 239.10 Mn |
| May 31, 2025 | 242.50 Mn |
| Feb 28, 2025 | 216.57 Mn |
| Nov 30, 2024 | 239.42 Mn |
| Aug 31, 2024 | 254.28 Mn |
| May 31, 2024 | 259.99 Mn |
| Feb 29, 2024 | 224.79 Mn |
| Nov 30, 2023 | 237.08 Mn |
| Aug 31, 2023 | 252.68 Mn |
| May 31, 2023 | 214.06 Mn |
| Feb 28, 2023 | 181.55 Mn |
| Nov 30, 2022 | 178.20 Mn |
| Aug 31, 2022 | 172.95 Mn |
| May 31, 2022 | 175.55 Mn |
| Feb 28, 2022 | 154.59 Mn |
| Nov 30, 2021 | 177.04 Mn |
| Aug 31, 2021 | 199.42 Mn |